<DOC>
	<DOCNO>NCT01130818</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single ascending ( SAD ) oral dose GLPG0492 compare placebo healthy subject . Also , pharmacokinetics ( PK ) pharmacodynamics ( PD ) GLPG0492 single oral administration evaluate , , applicable , maximum tolerate dose determine . Oral bioavailability ( solution v solid capsule fast feed ) evaluate healthy elderly subject .</brief_summary>
	<brief_title>First-in-Human Single Ascending Dose GLPG0492</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>healthy male , age 1850 year ( young subject ) OR ≥60 year ( elderly subject ) BMI 1830 kg/m² , inclusive nonsmoker elevate PSA drug alcohol abuse</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Bioavailability ( solid v solution , fast v fed )</keyword>
	<keyword>Young healthy subject</keyword>
	<keyword>Elderly healthy subject</keyword>
</DOC>